Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

ELACESTRANT HYDROCHLORIDE

FDA · NDA · 2026-06-24

AgencyFDA
Submission typeNDA
Action date2026-06-24
BrandORSERDU
SponsorSTEMLINE THERAP
RouteORAL

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T03:30:26.354Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:ELACESTRANT HYDROCHLORIDE:2026-06-24

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

ELACESTRANT HYDROCHLORIDE — approval | AEaH